Ranbaxy recalls 30,000 packs of allergy med; Sanofi produces more drugs at plant in Romania; New import alert for Indian plant;

> Ranbaxy has recalled nearly 30,000 packets of its loratadine and pseudoephedrine sulphate extended release tablets in the U.S. because of packaging issues. Story

> Sanofi ($SNY) last year transferred production or packaging of 22 drugs to its Zentiva factory in Romania. Report

> India's Shasun Pharmaceuticals has acquired from U.S.-based ScolorPharma the global rights to develop and sell 12-hour extended release ibuprofen tablets. Report

> The FDA has sent a warning letter to Greer Laboratories, which makes products for human and animal allergy testing. Letter

> The FDA says it will not take action against a Florida compounding pharmacy, and that the pharmacy can deal with issues under the auspices of state health authorities. Letter (PDF)

And Finally... The FDA has issued yet another import alert against an Indian company, this one for the infection fighter ceftazidime made by Aadivighnesh Chem at a plant in Mumbai, India. Alerts